http://www.fibrogen.com
FibroGen, Inc. Company Intro
FibroGen creates first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.
Industry
Healthcare
FibroGen, Inc. Headquaters
409 Illinois Street
San Francisco,94158
United States
FibroGen, Inc. Share price
17 May 2023 13:11 GMT
$17.32
-0.34 (-1.93 %)
FibroGen, Inc. Market cap
$1.71 B
WMC RANKING
2023
FibroGen, Inc. # 52
BiotechnologyLatest FibroGen, Inc. News
07 Dec 2023
Director Henderson Jeffrey William sale 2000 shares of ...
Over the course of the year, FibroGen Inc shares have dropped approximately -96.38%. Shares of the company reached a 52-week high of $25.6900 on 02/03/23 and a...
07 Dec 2023
Director Henderson Jeffrey William sale 2000 shares of ...
Over the course of the year, FibroGen Inc shares have dropped approximately -96.38%. Shares of the company reached a 52-week high of $25.6900 on 02/03/23 and a...
06 Dec 2023
Global Myelodysplastic Syndrome (MDS) Drugs Market Size ...
Reddy s Laboratories Ltd., Mylan NV, Cipla Limited, Acceleron Pharma, Inc., Aprea Therapeutics, FibroGen Inc., Onconova Therapeutics Inc., Geron, etc. Global...
WMC Market Score
WMC Market to Revenue Score
FibroGen, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| FibroGen, Inc. | USD | $190,347 | $360,280 | $-182,698 | $17,100B | 52 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total FibroGen, Inc. Social Followers vs Top 4 Industry Competitors
FibroGen, Inc. Post vs Top 4 Industry Competitors
FibroGen, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
FibroGen, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
FibroGen, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| FibroGen, Inc. | 2.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
